A new trading day began on January 24, 2023, with Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) stock priced at $8.61, down -1.38% from the previous day of trading. During the day, the shares moved up to $8.87 and dropped to $8.49 before settling in for the closing price of $8.71. RXRX’s price has ranged from $4.92 to $14.18 over the past 52 weeks.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Meanwhile, its annual earnings per share averaged -177.30%. With a float of $168.82 million, this company’s outstanding shares have now reached $173.44 million.
Let’s determine the extent of company efficiency that accounts for 400 employees. In terms of profitability, gross margin is +10.55, operating margin of -1795.79, and the pretax margin is -1832.18.
Recursion Pharmaceuticals Inc. (RXRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Recursion Pharmaceuticals Inc. is 5.50%, while institutional ownership is 68.70%. The most recent insider transaction that took place on Jan 17, was worth 91,561. In this transaction Chief Business Officer of this company sold 10,000 shares at a rate of $9.16, taking the stock ownership to the 73,160 shares. Before that another transaction happened on Jan 10, when Company’s 10% Owner bought 69,518 for $7.72, making the entire transaction worth $536,846. This insider now owns 12,321,732 shares in total.
Recursion Pharmaceuticals Inc. (RXRX) Recent Fiscal highlights
In its latest quarterly report, released on 6/29/2022, the company reported earnings of -$0.38 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -1832.18 while generating a return on equity of -47.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -177.30% per share during the next fiscal year.
Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) Trading Performance Indicators
Here are Recursion Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Recursion Pharmaceuticals Inc. (RXRX)
Looking closely at Recursion Pharmaceuticals Inc. (NASDAQ: RXRX), its last 5-days average volume was 0.86 million, which is a drop from its year-to-date volume of 0.96 million. As of the previous 9 days, the stock’s Stochastic %D was 57.70%. Additionally, its Average True Range was 0.58.
During the past 100 days, Recursion Pharmaceuticals Inc.’s (RXRX) raw stochastic average was set at 21.65%, which indicates a significant decrease from 62.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.94% in the past 14 days, which was lower than the 80.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.85, while its 200-day Moving Average is $8.87. However, in the short run, Recursion Pharmaceuticals Inc.’s stock first resistance to watch stands at $8.81. Second resistance stands at $9.03. The third major resistance level sits at $9.19. If the price goes on to break the first support level at $8.43, it is likely to go to the next support level at $8.27. Now, if the price goes above the second support level, the third support stands at $8.05.
Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) Key Stats
With a market capitalization of 1.59 billion, the company has a total of 189,556K Shares Outstanding. Currently, annual sales are 10,180 K while annual income is -186,480 K. The company’s previous quarter sales were 13,160 K while its latest quarter income was -60,450 K.